Prospective data also support this pattern: Sandhu et al. (2002) found that individuals with IGF-1 ≥152 μg/L had nearly 50% lower risk of impaired glucose tolerance or diabetes compared to those below this threshold [18]. This evidence concerns the gene IGF1 and Impaired glucose tolerance.